Odonate therapeutics, inc. (ODT)
Income statement / Yearly
Dec'19Dec'18Dec'17
Operating expenses:
Research and development

104,034

79,948

27,902

General and administrative

10,896

10,816

4,842

Total operating expenses

114,930

90,764

32,744

Loss from operations

-114,930

-90,764

-32,744

Interest income

3,105

1,804

-

Net loss

-111,825

-88,960

-32,744

Net loss per share:
Basic and diluted

-4.05

-3.64

-2.31

Weighted-average shares outstanding:
Basic and diluted

27,625

24,462

14,169